TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study.
Clinical trial NCT04392479 · UNKNOWN
Trial details
- NCT number
- NCT04392479
- Sponsor
- Hôpital Franco-Britannique-Fondation Cognacq-Jay
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-02
- Primary completion
- 2023-06-15
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.